Leo Borchardt

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Equinor ASA (f/k/a Statoil ASA) of $1 billion aggregate principal amount of 3.250% notes…

Davis Polk advised Centogene N.V. on its $56 million initial public offering of 4,000,000 of its common shares. In addition, Centogene has granted the underwriters a 30-day option to…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Diageo Capital plc of $600 million aggregate principal amount of 2.125% fixed-rate notes due 2024 and $1…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1.5 billion 1.625% guaranteed global notes…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1.5 billion 2.625% guaranteed global notes…

Davis Polk advised the dealer managers in connection with a cash tender offer by Koninklijke Ahold Delhaize N.V. for up to $350 million principal amount of its 5.70% senior notes due…

Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction, which is subject to customary closing conditions and the approval of…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1 billion 3.125% guaranteed global notes due…

Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $750 million aggregate principal amount of 3.250% notes due 2023 and $650 million aggregate…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Equinor ASA (f/k/a Statoil ASA) of $1 billion aggregate principal amount of 3.625%…